CASE REPORT
Stroke in the vascularization area of Percheron artery during treatment of severe pneumonia in a patient
with ulcerative colitis
1
Students’ Scientific Association at the Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland
2
Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
Submission date: 2025-01-20
Final revision date: 2025-05-08
Acceptance date: 2025-05-11
Publication date: 2025-09-24
Pediatr Pol 2025;61(3):294-298
KEYWORDS
TOPICS
ABSTRACT
Abstract
Stroke is an acute onset neurological event that is entirely vascular in origin. Patients with inflammatory bowel disease are at increased risk of thromboembolic events, and consideration of prophylactic anticoagulation in such patients with additional multiple risk factors seems justified.
The aim of this case report was to present a patient with severe ulcerative colitis undergoing biological therapy, who experienced a stroke in the vascularization area of Percheron artery during treatment of septic pneumonia. Due to severe course of ulcerative colitis, he was eligible for biological therapy. During hospitalization for pneumonia, patient developed neurological signs consistent with a stroke, confirmed by magnetic resonance imaging. Further investigations revealed factor von Leiden mutation and patent foramen ovale.
Given the rarity of stroke in the pediatric population, early and accurate diagnosis is important to start appropriate treatment as soon as possible.
Stroke is an acute onset neurological event that is entirely vascular in origin. Patients with inflammatory bowel disease are at increased risk of thromboembolic events, and consideration of prophylactic anticoagulation in such patients with additional multiple risk factors seems justified.
The aim of this case report was to present a patient with severe ulcerative colitis undergoing biological therapy, who experienced a stroke in the vascularization area of Percheron artery during treatment of septic pneumonia. Due to severe course of ulcerative colitis, he was eligible for biological therapy. During hospitalization for pneumonia, patient developed neurological signs consistent with a stroke, confirmed by magnetic resonance imaging. Further investigations revealed factor von Leiden mutation and patent foramen ovale.
Given the rarity of stroke in the pediatric population, early and accurate diagnosis is important to start appropriate treatment as soon as possible.
REFERENCES (22)
1.
Sporns PB, Fullerton HJ, Lee S, et al. Childhood stroke. Nat Rev Dis Primers 2022; 8: 12. DOI: 10.1038/s41572-022-00337-x.
2.
Pilarska E, Kopyta I, Szurowska E, et al. Polish recommendations for diagnosis and therapy of paediatric stroke. Neurol Neurochir Pol 2023; 57: 243-260.
3.
Ferriero DM, Fullerton HJ, Bernard TJ, et al. American Heart Association Stroke Council and Council on Cardiovascular and Stroke Nursing. Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association. Stroke 2019; 50: e51-e96. DOI: 10.1161/STR.0000000000000183.
4.
Herrero MT, Barcia C, Navarro JM. Functional anatomy of thalamus and basal ganglia. Childs Nerv Syst 2002; 18: 386-404.
5.
Kamińska K, Tarasiuk J, Jakubowicz-Lachowska D, et al. Obustronny udar niedokrwienny wzgórza w zakresie unaczynienia tętnicy Percherona. Polski Przegląd Neurologiczny 2016; 12: 178-182.
6.
Rodriguez EG, Lee JA. Bilateral thalamic infarcts due to occlusion of the Artery of Percheron and discussion of the differential diagnosis of bilateral thalamic lesions. J Radiol Case Rep 2013; 7: 7-14.
7.
Kichloo A, Jamal SM, Zain EA, et al. Artery of Percheron infarction: a short review. J Investig Med High Impact Case Rep 2019; 7: 2324709619867355. DOI: 10.1177/2324709619867355.
8.
Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010; 375: 657-663.
9.
Barclay AR, Keightley JM, Horrocks I, et al. Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2010; 16: 677-683.
10.
Cheng K, Faye AS. Venous thromboembolism in inflammatory bowel disease. World J Gastroenterol 2020; 26: 1231-1241.
11.
Dhaliwal G, Patrone MV, Bickston SJ. Venous thromboembolism in patients with inflammatory bowel disease. J Clin Med 2023; 13: 251. DOI: 10.3390/jcm13010251.
12.
Witmer CM, Takemoto CM. Pediatric hospital acquired venous thromboembolism. Front Pediatr 2017; 5: 198. DOI: 10.3389/fped.2017.00198.
13.
Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008; 103: 2272-2280.
14.
Sarlos P, Szemes K, Hegyi P, et al. Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease: a meta-analysis. J Crohns Colitis 2018; 12: 489-498.
15.
Mahajerin A, Branchford BR, Amankwah EK, et al. Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk-assessment models. Haematologica 2015; 100: 1045-1050.
16.
Charles-Schoeman C, Fleischmann R, Mysler E, et al. Risk of venous thromboembolism with tofacitinib versus tumor necrosis factor inhibitors in cardiovascular risk-enriched rheumatoid arthritis patients. Arthritis Rheumatol 2024; 76: 1218-1229.
17.
Eder P, Dobrowolska A. Tofacitinib – nowy lek w terapii nieswoistych chorób zapalnych jelit. Forum Reumatologiczne 2021; 7: 13-18.
18.
Miller M, Patel AS, Pasternak B, et al. Rescue therapy with upadacitinib in medically refractory pediatric ulcerative colitis. JPGN Rep 2024; 5: 197-199.
19.
Ledder O, Dolinger M, Dubinsky MC, et al. Tofacitinib in pediatric ulcerative colitis: a retrospective multicenter experience. Inflamm Bowel Dis 2025; 31: 425-431.
20.
Atallah O, Almealawy YF, Alabide AS, et al. Navigating the clinical landscape of artery of Percheron infarction: a systematic review. eNeurologicalSci 2024; 37: 100521. DOI: 10.1016/j.ensci.2024.100521.
22.
Turner D, Ruemmele FM, Orlanski-Meyer E, et al. Management of paediatric ulcerative colitis, part 2: acute severe colitis – an evidence-based consensus guideline from the European Crohn’s and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018; 67: 292-310.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
